共查询到20条相似文献,搜索用时 156 毫秒
1.
2.
3.
干细胞概述 总被引:7,自引:0,他引:7
干细胞是存在于胚胎和成体中的一类特殊细胞,它能长期地自我更新,在特定的条件下具有分化形成多种终末细胞的能力,不同来源的干细胞分化潜能各异。从早期胚胎内细胞团分离的胚胎干细胞能分化形成个体所有的细胞类型,并具有在体外无限增殖的能力,是最具有临床应用前景和研究价值的干细胞之一。在成体各种组织和器官中也存在成体干细胞,用于维持机体结构和功能的稳态。近期有关成体干细胞可塑性的研究和成体组织中多能干细胞存在的证据扩大了人们对成体干细胞分化潜能的认识。干细胞具有的多向分化潜能和自我更新能力使其成为未来再生医学的重要种子细胞,并成为研究人类早期胚层特化和器官形成、药物筛选以及基因治疗的最佳工具。 相似文献
4.
胚胎干细胞在不同的诱导条件下具有多向分化的潜能,多种胞内外信号途径参与其分化过程的调控。现就胚胎干细胞向血管内皮细胞分化的诱导条件及分子机制做一综述,并阐明不同阶段的内皮前体细胞所表达的不同分子标志,同时提出胚胎干细胞在再生医学中的应用前景。 相似文献
5.
干细胞是一类具有多向分化潜能的细胞群,如胚胎干细胞(embryonic stem cell,ESC)、诱导多潜能干细胞(induced pluripotent stem cell,i PSC)等,可在特定的条件下向包括视网膜感光细胞在内的多种细胞分化。小分子化合物是一类由组织细胞合成、分泌的小分子多肽类因子,特定的小分子化合物可作用于干细胞诱导其向视网膜感光细胞分化。目前,对干细胞体外培养,通过使用不同的诱导培养方案,探索干细胞向视网膜感光细胞分化的研究成为热点。早期,研究者们主要在共培养条件下采用小分子化合物诱导ESC向视网膜感光细胞分化,随着研究的进展,逐渐开始探索在无共培养条件下小分子化合物诱导ESC向视网膜感光细胞的分化以及小分子化合物诱导i PSC向视网膜感光细胞的分化。本文主要就小分子化合物促进ESC和i PSC向视网膜感光细胞分化的研究进展进行综述。 相似文献
6.
造血干细胞移植已成为治疗白血病、再生障碍性贫血、重症免疫缺陷征、地中海贫血、急性放射病、某些恶性实体瘤和淋巴瘤等造血及免疫系统功能障碍性疾病的成熟技术和重要手段,另外这一技术还被尝试用于治疗艾滋病,已取得积极的效果。但是由于移植需要配型相同的供体,并且过程复杂,使得造血干细胞移植因缺少配型相同的供体来源以及费用昂贵而不能被广泛应用。胚胎干细胞是一种能够在体外保持未分化状态并且能进行无限增殖的细胞,在适合条件下能够分化为体内各种类型的细胞,研究胚胎干细胞分化为造血干细胞,不仅可作为研究动物的早期造血发生的模型,而且可以增加造血干细胞的来源,还可以通过基因剔除、治疗性克隆等方法来解决移植排斥的问题,从而为造血干细胞移植的发展扫除了障碍,因此有着重要的研究价值和应用前景。现对胚胎干细胞体外分化为造血干细胞的诱导方法,诱导过程中的调控机制,并对胚胎干细胞分化为造血干细胞的存在问题和发展前景进行讨论。 相似文献
7.
小鼠胚胎干细胞体外发育分化模型 总被引:2,自引:0,他引:2
胚胎干细胞 (Embryonicstemcell ,EScell)是多潜能性细胞 ,它在体外既可维持不分化而无限增殖 ,又能参与胚胎发育分化为各种类型细胞和组织而形成器官 ;小鼠ES细胞可供的数量大、在体外培养条件可进行精确调控、实验比较经济加上现代基因及其他生物操作等技术 ,因此小鼠ES细胞体外发育分化系统被广泛地作为模型系统加以利用。小鼠ES细胞体外发育分化研究为推动其他哺乳类动物以及人的ES细胞研究 ,从而将更好地进行细胞、组织工程实验为人类细胞组织和基因治疗服务创造了有利条件。本文将ES细胞体外发育分化情况加以概述 ,以便更好地开展ES细胞体外研究 相似文献
8.
胚胎干细胞是具有分化为各种类型组织细胞潜能的全能干细胞,可在体外大量扩增,细胞因子、激素、诱导剂和细胞内转录因子等可诱导和调控胚胎干细胞进行心肌细胞定向分化.这将使干细胞移植治疗心肌损伤性疾病成为可能。该文介绍胚胎干细胞定向心肌分化的诱导因素及其机制的研究进展。 相似文献
9.
10.
11.
12.
13.
小鼠胚胎干细胞建系技术研究进展 总被引:4,自引:0,他引:4
目前,对小鼠胚胎干细胞的研究较为深入,并已成为研究细胞分化及信号转导、新基因发现及功能鉴定、器官发生、人类疾病和药物开发等的有效手段。胚胎干细胞建系是一项基础性工作。虽然技术日趋成熟,有些品系小鼠的胚胎干细胞建系已是常规技术,但不同品系小鼠胚胎干细胞的建系效率仍有很大差异,建系途径和方法各有特点,一个品系胚胎干细胞的建系方法不一定都适用于其他品系。本文从小鼠胚胎干细胞建系的途径、分离操作技术、培养体系等方面进行综述,并就与之相关的有些问题提出思考和对策。 相似文献
14.
Stem cells, such as embryonic stem cells, hematopoietic stem cells, neural stem cells, mesenchymal stem cells, and very small embryonic-like stem cells, are undifferentiated cells that are endowed with a high potential for proliferation and the capacity for self-renewal with retention of pluri/multipotency to differentiate into their progenies. Recently, studies regarding the biological functions of glycolipids and cell surface microdomains (caveolae, lipid rafts, or glycolipid-enriched microdomains) in stem cells are emerging. In this review, we introduce the expression patterns of glycolipids and the functional roles of cell surface microdomains in stem cells. 相似文献
15.
The role of stem cells in cardiac regeneration 总被引:18,自引:0,他引:18
Smits AM van Vliet P Hassink RJ Goumans MJ Doevendans PA 《Journal of cellular and molecular medicine》2005,9(1):25-36
After myocardial infarction, injured cardiomyocytes are replaced by fibrotic tissue promoting the development of heart failure. Cell transplantation has emerged as a potential therapy and stem cells may be an important and powerful cellular source. Embryonic stem cells can differentiate into true cardiomyocytes, making them in principle an unlimited source of transplantable cells for cardiac repair, although immunological and ethical constraints exist. Somatic stem cells are an attractive option to explore for transplantation as they are autologous, but their differentiation potential is more restricted than embryonic stem cells. Currently, the major sources of somatic cells used for basic research and in clinical trials originate from the bone marrow. The differentiation capacity of different populations of bone marrow-derived stem cells into cardiomyocytes has been studied intensively. The results are rather confusing and difficult to compare, since different isolation and identification methods have been used to determine the cell population studied. To date, only mesenchymal stem cells seem to form cardiomyocytes, and only a small percentage of this population will do so in vitro or in vivo. A newly identified cell population isolated from cardiac tissue, called cardiac progenitor cells, holds great potential for cardiac regeneration. Here we discuss the potential of the different cell populations and their usefulness in stem cell based therapy to repair the damaged heart. 相似文献
16.
Application of RNA interference to study stem cell function: current status and future perspectives 总被引:5,自引:0,他引:5
Zou GM Yoder MC 《Biology of the cell / under the auspices of the European Cell Biology Organization》2005,97(3):211-219
RNA interference is a mechanism displayed by most eukaryotic cells to rid themselves of foreign double-stranded RNA molecules. In the six years since the initial report, RNA interference has now been demonstrated to function in mammalian cells to alter gene expression, and has been used as a means for genetic discovery as well as a possible strategy for genetic correction. An equally popular topic over the past six years has been the proposal to utilize embryonic stem cells or adult stem cells as cell-based therapies for human diseases. The aim of this review is to provide a general overview of how RNA interference suppresses gene expression and to examine some published RNA interference approaches that have resulted in changes in stem cell function and suggest the possible clinical relevance of this work. 相似文献
17.
Mammalian embryonic stem cells have the potential to differentiate into all cell types of an adult individual. The culturing
of human embryonic stem cells renders possible studies that were previously only available in animal models. Embryonic stem
cells constitute a particularly attractive tool for studies of self-renewal, commitment, differentiation, maturation and cell-cell
interaction. There is currently considerable hope that studies of embryonic stem cells will lead to new therapies; either
by themselves, through cell replacement strategies, or by generating results assisting other fields of research to reach clinical
results. There are, however, considerable challenges to be met before embryonic stem cells can be used in large-scale clinical
trials.Stem cell research is an area that has given rise to much debate internationally, within science, law and politics
as well as within philosophy and ethics. The ethical attitudes expressed in the public debate over stem cell research notably
divide over three important distinctions: (1) Reproductive versus therapeutic cloning; (2) Using already existing embryos
versus producing new embryos for research purposes; (3) Production of embryos from eggs and sperm versus through somatic-cell
nuclear transfer. The potential medical benefits that may result from embryonic stem cell research arguably support a continued
development in this area. However, some opponents argue that this research offends the (relative or absolute) moral status
of an unborn human. Furthermore, the research would probably prove to be a both time-consuming and very expensive method for
treating disease. Thus, the questions arise whom the new technique wouldbenefit and at what cost, if ever developed.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
18.
胚胎干细胞的分化控制是胚胎干细胞研究的一个重要方面。由于常规的拟胚体诱导途径是在形成拟胚体后才开始进行诱导分化,受多种胚层的共同作用使得我们无法简便探索诱导分化的机制。而且用这种方法进行的诱导分化试验的结果检测比 相似文献
19.
Masayo Sakaki-Yumoto Yoko KatsunoRik Derynck 《Biochimica et Biophysica Acta (BBA)/General Subjects》2013
Background
The diversity of cell types and tissue types that originate throughout development derives from the differentiation potential of embryonic stem cells and somatic stem cells. While the former are pluripotent, and thus can give rise to a full differentiation spectrum, the latter have limited differentiation potential but drive tissue remodeling. Additionally cancer tissues also have a small population of self-renewing cells with stem cell properties. These cancer stem cells may arise through dedifferentiation from non-stem cells in cancer tissues, illustrating their plasticity, and may greatly contribute to the resistance of cancers to chemotherapies.Scope of review
The capacity of the different types of stem cells for self-renewal, the establishment and maintenance of their differentiation potential, and the selection of differentiation programs are greatly defined by the interplay of signaling molecules provided by both the stem cells themselves, and their microenvironment, the niche. Here we discuss common and divergent roles of TGF-β family signaling in the regulation of embryonic, reprogrammed pluripotent, somatic, and cancer stem cells.Major conclusions
Increasing evidence highlights the similarities between responses of normal and cancer stem cells to signaling molecules, provided or activated by their microenvironment. While TGF-β family signaling regulates stemness of normal and cancer stem cells, its effects are diverse and depend on the cell types and physiological state of the cells.General significance
Further mechanistic studies will provide a better understanding of the roles of TGF-β family signaling in the regulation of stem cells. These basic studies may lead to the development of a new therapeutic or prognostic strategies for the treatment of cancers. This article is part of a Special Issue entitled Biochemistry of Stem Cells. 相似文献20.
骨髓移植是目前治疗恶性白血病以及遗传性血液病最有效的方法之一。但是HLA相匹配的骨髓捐献者严重短缺,骨髓造血干细胞(hematopoietic stem cells,HSCs)体外培养困难,在体外修复患者骨髓造血干细胞技术不成熟,这些都大大限制了骨髓移植在临床上的应用。多能性胚胎干细胞(embryonic stem cells,ESCs)具有自我更新能力,在合适的培养条件下分化形成各种血系细胞,是造血干细胞的另一来源。在过去的二十多年里,血发生的研究是干细胞生物学中最为活跃的领域之一。小鼠及人的胚胎干细胞方面的研究最近取得了重大进展。这篇综述总结了近年来从胚胎干细胞获得造血干细胞的成就,以及在安全和技术上的障碍。胚胎干细胞诱导生成可移植性血干细胞的研究能够使我们更好地了解正常和异常造血发生的机制,同时也为造血干细胞的临床应用提供理论和实验依据。 相似文献